Alpine Immune Sciences, Inc. (ALPN): Price and Financial Metrics

ALPN POWR Grades

• Quality is the dimension where ALPN ranks best; there it ranks ahead of 76.3% of US stocks.
• The strongest trend for ALPN is in Momentum, which has been heading up over the past 177 days.
• ALPN's current lowest rank is in the Growth metric (where it is better than 9% of US stocks).

ALPN Stock Summary

• Of note is the ratio of ALPINE IMMUNE SCIENCES INC's sales and general administrative expense to its total operating expenses; just 8.47% of US stocks have a lower such ratio.
• With a price/sales ratio of 11.83, ALPINE IMMUNE SCIENCES INC has a higher such ratio than 91.44% of stocks in our set.
• With a year-over-year growth in debt of -27.55%, ALPINE IMMUNE SCIENCES INC's debt growth rate surpasses merely 10.72% of about US stocks.
• If you're looking for stocks that are quantitatively similar to ALPINE IMMUNE SCIENCES INC, a group of peers worth examining would be SGMO, IDYA, GRTS, PSTX, and TNGX.
• Visit ALPN's SEC page to see the company's official filings. To visit the company's web site, go to www.alpineimmunesciences.com.

ALPN Valuation Summary

• In comparison to the median Healthcare stock, ALPN's price/sales ratio is 521.05% higher, now standing at 11.8.
• ALPN's price/sales ratio has moved NA NA over the prior 95 months.

Below are key valuation metrics over time for ALPN.

ALPN Growth Metrics

The year over year net income to common stockholders growth rate now stands at -42.87%.
• Its 2 year price growth rate is now at 120%.
• Its 5 year net income to common stockholders growth rate is now at -7.57%.

Over the past 33 months, ALPN's revenue has gone up $30,078,000.

The table below shows ALPN's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2022-09-30	31.818	-41.697	-54.065
2022-06-30	31.967	4.785	-54.286
2022-03-31	33.868	6.172	-47.217
2021-12-31	23.443	-15.248	-50.333
2021-09-30	24.556	-9.868	-41.508
2021-06-30	17.953	-45.394	-34.151

ALPN's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• ALPN has a Quality Grade of C, ranking ahead of 68.11% of graded US stocks.
• ALPN's asset turnover comes in at 0.122 -- ranking 247th of 682 Pharmaceutical Products stocks.
• SELB, TXMD, and QGEN are the stocks whose asset turnover ratios are most correlated with ALPN.

The table below shows ALPN's key quality metrics over time.